Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Clinical Trials
Posted inClinical Trials, Infections
Ycanth: First Treatment for Molluscum Contagiosum and Warts
Cantharidin Verrica Pharmaceuticals can help get rid of common viral skin lesions.
Posted inClinical Trials, COVID-19, Infections
Kropsen: Strong New Pill to Treat COVID-19 Infection
Oral proxalutamide by Chinese Kintor Pharmaceutical effectively treats COVID-19 in outpatients and inpatients.
Posted inClinical Trials, COVID-19, Infections, Research
Favipiravir to Treat COVID-19. Most Comprehensive Review in World
What benefit we should expect from favipiravir in the fight against coronavirus?
Posted inClinical Trials, COVID-19, Infections
Upamostat: Oral Medication for COVID-19
Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.
Posted inClinical Trials, COVID-19, Infections, Oncology
Yeliva: New Drug for COVID-19
Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
Posted inClinical Trials, Metabolism, Neuroscience, Rare/Orphan Diseases
Redasemtide: Universal Medicine for Regeneration of Any Tissue
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.